Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Relay Therapeutics Inc
(NQ:
RLAY
)
6.790
+0.030 (+0.44%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Relay Therapeutics Inc
< Previous
1
2
Next >
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer
March 24, 2023
FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 24, 2023 – USA News Group – Treatments for various forms of breast cancer continue to evolve, with several new breakthroughs...
Via
FinancialNewsMedia
Relay Therapeutics to Present Initial Clinical Data on RLY-2608 at AACR
March 06, 2023
Relay Therapeutics to host conference call following AACR presentation
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Relay Therapeutics to Participate in Two Upcoming Investor Conferences
March 01, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Relay Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights
February 23, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Relay Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights
February 16, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Relay Therapeutics to Participate in Guggenheim Healthcare Talks | Oncology Day
February 02, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Relay Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Relay Therapeutics to Participate in Two Upcoming Investor Conferences
November 07, 2022
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Relay Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights
November 03, 2022
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Relay Therapeutics to Announce Third Quarter 2022 Financial Results and Corporate Highlights
October 27, 2022
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Foundation Medicine and Relay Therapeutics Collaborate to Develop FoundationOne®CDx as a Companion Diagnostic for Relay’s Investigational FGFR2 Inhibitor, RLY-4008
September 12, 2022
From
Foundation Medicine
Via
Business Wire
Relay Therapeutics to Announce Second Quarter 2022 Financial Results and Corporate Highlights
July 28, 2022
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.